Código QR (código de barras bidimensional)

Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Abstract Introduction Atopic dermatitis (AD) is a chronic skin disease largely driven by interleukin (IL)-13, which is targeted by tralokinumab and lebrikizumab. Effective, long-term treatments are needed, and head-to-head studies comparing these available therapeutics have yet to be conducted. This...

תיאור מלא

שמור ב:
Principais autores: Matthias Augustin, April Armstrong, Naiem T. Issa, Anne Sohrt Petersen, Rie von Eyben, Teodora Festini, Tiago Torres
פורמט: Artigo
שפה:Inglês
יצא לאור: Adis, Springer Healthcare 2025-10-01
סדרה:Dermatology and Therapy
נושאים:
Atopic dermatitis
Lebrikizumab
Long-term disease management
Maintenance of efficacy
Matching-adjusted indirect comparison
Tralokinumab
גישה מקוונת:https://doi.org/10.1007/s13555-025-01563-3
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים